In contrast to a recent study, despite being the closest homolog of PLXDC2, PLXDC1 was not significantly differentially expressed between tumor samples and normal samples at the gene level, leaving PLXDC2 as the only TEM suitable for predicting the survival outcomes of GC (Zhang et al., 2015). This evidence concerns the gene PLXDC2 and neoplasm.